Forte Biosciences, Inc. · NASDAQ:FBRX

Affinity Asset Advisors, LLC reported a 6.90% stake in Forte Biosciences, Inc. (Schedule 13G)

Event Dec 17, 2025 · Filed Dec 23, 2025

Affinity Asset Advisors, LLC reported a 6.90% stake in Forte Biosciences, Inc., 862,400 shares, as a passive investor on Dec 17, 2025. Filed Dec 23, 2025 (Schedule 13G).

Stake
6.90%
Shares
862,400
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC6.90%862,400
Affinity Healthcare Fund, LP6.90%862,400

Source

View original at SEC

Related